Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 705-710

  Esposito, Susanna ^a   Marchese, Anna ^c   Tozzi, Alberto E ^c   Rossi, Giovanni A ^d   Dalt, Liviana Da ^e   Bona, Gianni ^f   Pelucchi, Claudio ^g   Schito, Gian Carlo ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Children; Community acquired pneumonia; Pneumococcal conjugate vaccines; Pneumococcal serotypes; Streptococcus pneumoniae

Indexed keywords

C REACTIVE PROTEIN; PNEUMOCOCCUS VACCINE;

ARTICLE; ATELECTASIS; BACTEREMIA; BLOOD CULTURE; CHILD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EMPYEMA; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; ITALY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NECROTIZING PNEUMONIA; NEUTROPHIL COUNT; NEWBORN; PLEURA EFFUSION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; ITALY; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84862760295     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825384ae     Document Type: Article

References (39)

1. Williams BG, Gouws E, Boschi-Pinto C, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2:25-32. (Pubitemid 36109303)
2. Centers for Disease Control and Prevention. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine United States, 1997-2006. MMWR Morb Mortal Wkly Rep. 2009;58:1-4.
3. Esteva C, Selva L, de Sevilla MF, et al. Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989-2008). Clin Microbiol Infect. 2011;17:1441-1444.
4. Bender JM, Ampofo K, Korgenski K, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46:1346-1352. (Pubitemid 351589931)
5. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect. 2009;15(suppl 3):16-20.
6. Ansaldi F, Canepa P, de Florentiis D, et al. Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. Clin Vaccine Immunol. 2011;18:343-345.
7. Picazo J, Ruiz-Contreras J, Hernandez B, et al. Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid. Vaccine. 2011;29:1770-1776.
8. Techasaensiri C, Messina AF, Katz K, et al. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J. 2010;29:294-300.
9. Croxtall JD, Keating GM. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs. 2009;11:349-357.
10. Bryant KA, Block SL, Baker SA, et al.; PCV13 Infant Study Group. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866-875.
11. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197-e209.
12. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76.
13. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(suppl 2):ii1-ii23.
14. Corless CE, Guiver M, Borrow R, et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39:1553-1558. (Pubitemid 32275465)
15. Azzari C, Moriondo M, Indolfi G, et al. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One. 2010;5:e9282.
16. Resti M, Moriondo M, Cortimiglia M, et al.; Italian Group for the Study of Invasive Pneumococcal Disease. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51:1042-1049.
17. World Health Organization. Pneumonia Vaccine Trial Investigators' Group. Standardization of Interpretation of Chest Radiographs for the Diagnosis of Pneumonia in Children. WHO/V&B/01.35. Geneva, Switzerland: World Health Organization; 2001.
18. Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110(1 Pt 1):1-6. (Pubitemid 34742634)
19. Sawicki GS, Lu FL, Valim C, et al. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008;31:1285-1291.
20. Sheppard CL, Harrison TG, Morris R, et al. Autolysin-targeted LightCycler assay including internal process control for detection of Streptococcus pneumoniae DNA in clinical samples. J Med Microbiol. 2004;53(Pt 3):189-195. (Pubitemid 38340117)
21. Tarragó D, Fenoll A, Sánchez-Tatay D, et al. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect. 2008;14:828-834.
22. Park HK, Lee HJ, Lee HJ, et al. Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae. FEMS Microbiol Lett. 2010;310:48-53.
23. Hoorfar J, Malorny B, Abdulmawjood A, et al. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J Clin Microbiol. 2004;42:1863-1868. (Pubitemid 38637794)
24. Marchese A, Esposito S, Coppo E, et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children <5 years of age with community-acquired pneumonia. Microb Drug Resist. 2011; 17: 419-424
25. Ramirez M, Melo-Cristino J. Expanding the diagnosis of pediatric bacteremic pneumococcal pneumonia from blood cultures to molecular methods: advantages and caveats. Clin Infect Dis. 2010;51:1050-1052.
26. Azzari C, Cortimiglia M, Moriondo M, et al. Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene. J Med Microbiol. 2011;60(Pt 6):710-714.
27. Shah SS, Alpern ER, Zwerling L, et al. Risk of bacteremia in young children with pneumonia treated as outpatients. Arch Pediatr Adolesc Med. 2003;157:389-392. (Pubitemid 36443712)
28. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369: 1179-1186. (Pubitemid 46527876)
29. Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther. 2009;31:1266-1273.
30. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522-525. (Pubitemid 38797527)
31. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis. 2002;35:1345-1352. (Pubitemid 35448962)
32. Hsu KK, Shea KM, Stevenson AE, et al.; Massachusetts Department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J. 2010;29: 289-293.
33. Ampofo K, Pavia AT, Stockmann C, et al. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012;31:228-234.
34. McIntosh ED, Reinert RR. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev Vaccines. 2011;10:109-129.
35. Yu J, Salamon D, Marcon M, et al. Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol. 2011;49:534-538.
36. Esposito S, Madore DV, Gironi S, et al. Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy. Vaccine. 2003;21:2704-2707. (Pubitemid 36703180)
37. Esposito S, Pugni L, Bosis S, et al. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre-and full-term infants. Vaccine. 2005;23:1703-1708. (Pubitemid 40215704)
38. Deceuninck G, De Wals P, Boulianne N, et al. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada. Pediatr Infect Dis J. 2010;29:546-549.
39. Vestrheim DF, Løvoll O, Aaberge IS, et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26: 3277-3281.